Clinical Trial Update: Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis [Phase 3]

View source ↗

Summary

Follow-up efficacy and safety data from a Phase 3 trial of alitretinoin in severe chronic hand dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Dermatitis

Drugs mentioned

• Alitretinoin (alitretinoin)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Hand Dermatoses | Phase 3 | Status: COMPLETED